Cutera (NASDAQ:CUTR) Now Covered by StockNews.com

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Friday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Down 63.9 %

Shares of Cutera stock opened at $0.04 on Friday. The company has a market capitalization of $787,254.00, a price-to-earnings ratio of -0.01 and a beta of 1.36. The stock’s 50-day simple moving average is $0.20 and its 200-day simple moving average is $0.39. Cutera has a 52 week low of $0.09 and a 52 week high of $3.00.

Institutional Investors Weigh In On Cutera

An institutional investor recently raised its position in Cutera stock. Geode Capital Management LLC lifted its stake in Cutera, Inc. (NASDAQ:CUTR) by 25.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 248,257 shares of the medical device company’s stock after buying an additional 50,046 shares during the quarter. Geode Capital Management LLC owned approximately 1.23% of Cutera worth $88,000 at the end of the most recent reporting period. 90.70% of the stock is owned by institutional investors and hedge funds.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.